Shore Capital restated their house stock rating on shares of Destiny Pharma (LON:DEST – Free Report) in a report published on Monday morning, MarketBeat.com reports.
Destiny Pharma Price Performance
DEST stock opened at GBX 4.25 ($0.06) on Monday. Destiny Pharma has a 1-year low of GBX 2 ($0.03) and a 1-year high of GBX 84 ($1.09). The business has a fifty day moving average price of GBX 12.03 and a 200-day moving average price of GBX 29.93. The stock has a market capitalization of £4.05 million, a P/E ratio of -70.83 and a beta of 0.31.
About Destiny Pharma
Recommended Stories
- Five stocks we like better than Destiny Pharma
- Transportation Stocks Investing
- This Cybersecurity Stock Gains Analysts’ Favor for Strong Growth
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Parabolic Rise of This Stock Shows No Signs of Slowing
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Risk Tolerance vs. Risk Appetite: Key Differences
Receive News & Ratings for Destiny Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Destiny Pharma and related companies with MarketBeat.com's FREE daily email newsletter.